Vector BioPharma is a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery, to improve treatments for patients. Incorporating cutting-edge platform technologies, from world-class academic research at the University of Zürich, Vector BioPharma uses engineered adenoviral vectors to achieve cell- and tissue-specific delivery, and tunable expression of genes and regulators with unprecedented precision.
| Website | https://www.vectorbiopharma.com/ |
| Employees | 23 (1 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Advanced Drug Delivery Systems, Drug Delivery, Drug Efficacy, Drug Safety, Pharmaceutical Technology, Pharmaceutical Research, Targeted Therapies, Therapeutic Solutions, Patient Treatment, New Drug Development, Drug Development, Pharmaceutical Innovation, Clinical Trials, Biomedical Research, Healthcare Innovation, Biotechnology, Life Sciences, Precision Medicine, Innovative Therapies |
| Competitors | Roche, Novartis, Merck & Co., Inc., Pfizer, Sanofi, AstraZeneca, Bristol Myers Squibb, Amgen, Gilead Sciences, Moderna Therapeutics +40 more (view full list) |
Looking for a particular Vector BioPharma employee's phone or email?
1 people are employed at Vector BioPharma.
Vector BioPharma is based in Basel, Basel City.